Rifampin
- Product NDC
- 53002-6430
- 11-digit product format
- 530026430
- Labeler code
- 53002
- Product ID
- 53002-6430_e6bcd207-0a10-4a55-b148-1c73d8da2acb
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Rifampin
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA064150
- Marketing category
- ANDA
- Marketing start
- 1997-05-28
- Marketing end
- 0000-00-00
- Substance
- RIFAMPIN
- Active strength
- 300 mg/1
- Pharmacologic classes
- Rifamycin Antibacterial [EPC],Rifamycins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
NDC, Effective, Action table| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|
| 53002-6430-2 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-3 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-6 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-7 | 2023-01-30 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-2 | 2020-12-17 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-3 | 2020-12-17 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-6 | 2020-12-17 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-7 | 2020-12-17 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-2 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-3 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-6 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
| 53002-6430-7 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-e8a8-f424-e053-dadaa90a57ce | Rifampin Capsules, USP |
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-6430-2 | Rifampin | 20 in 1 BOTTLE | CAPSULE | 20 | | 3 |
| 53002-6430-3 | Rifampin | 30 in 1 BOTTLE | CAPSULE | 30 | | 3 |
| 53002-6430-6 | Rifampin | 60 in 1 BOTTLE | CAPSULE | 60 | | 3 |
| 53002-6430-7 | Rifampin | 70 in 1 BOTTLE | CAPSULE | 70 | | 3 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-6430 | RIFAMPIN CAPSULE [RPK PHARMACEUTICALS, INC.] | 3 | Legacy NDC, 4 package rows | 20201218_4905542c-83a5-4507-a7cf-94f827119c60.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-6430-2 | 53002643002 | 20 CAPSULE in 1 BOTTLE (53002-6430-2) | 20 capsule | 2018-10-01 | 0000-00-00 | No | No | Current |
| 53002-6430-3 | 53002643003 | 30 CAPSULE in 1 BOTTLE (53002-6430-3) | 30 capsule | 2018-10-01 | 0000-00-00 | No | No | Current |
| 53002-6430-6 | 53002643006 | 60 CAPSULE in 1 BOTTLE (53002-6430-6) | 60 capsule | 2018-10-01 | 0000-00-00 | No | No | Current |
| 53002-6430-7 | 53002643007 | 70 CAPSULE in 1 BOTTLE (53002-6430-7) | 70 capsule | 2018-10-01 | 0000-00-00 | No | No | Current |